Cardiogen (sequence: Ala-Glu-Asp-Arg or AEDR) is a synthetic tetrapeptide bioregulator designed primarily to target, protect, and regenerate cardiovascular tissues. Preclinical research indicates that it works at a cellular and epigenetic level to modify gene expression rather than just masking symptoms.
Key Benefits of CardiogenCardiac Repair and Regeneration: It stimulates the proliferation of cardiomyocytes (heart muscle cells), enhancing the heart’s contraction power and improving its ability to heal after injuries like a myocardial infarction.Reduction of Scar Tissue (Fibrosis): Cardiogen modulates fibroblast activity to downregulate the overproduction of connective tissue. This prevents heavy scarring after a heart attack, ensuring the tissue remains functional and flexible.Cellular Protection Against Stress: It suppresses premature apoptosis (programmed cell death) in healthy myocardial cells by decreasing p53 protein expression. This shields heart tissue from oxidative damage, metabolic stress, and chronic inflammation.